Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
health decrease » deaths decreased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
health decrease » deaths decreased (Expand Search)
-
3561
-
3562
-
3563
-
3564
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
3565
-
3566
-
3567
-
3568
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
3569
-
3570
-
3571
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
3572
-
3573
-
3574
-
3575
-
3576
-
3577
-
3578
-
3579
-
3580
Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>.
Published 2025Subjects: